KAUST R3T News
19 February, 2024Giving voice to the voiceless through assistive technology
Artificial skin coupled with sensors and machine learning technology allows people with voice disorders to communicate using soundless mouth movements.
28 January, 2024KAUST and amplifAI health combine technologies for early diabetes detection
The partnership aims to significantly lower medical costs and protect patients from foot amputations.
16 January, 2024Automated COVID-19 diagnosis, with wider potential
An open-source, automated and cost-effective platform for COVID-19 diagnosis and analysis of genetic variants can be built from readily available materials, with big possibilities on the horizon.
04 December, 2023The weird and wonderful world of Saudi Arabia’s microbiomes
Saudi Arabia is home to microbial communities that can boost coral reef health, sequester carbon in the desert and enable plants to survive in the harshest environments — and that is just the beginning.
25 October, 2023Malaria protein discovery offers path for novel antimalarial intervention strategies
The discovery of a recent malaria protein by Amit Kumar Subudhi and Professor Arnab Pain could lead to the development of vaccine-like “immune triggers“ for warding off natural malaria infections in people.
12 October, 2023Picking the best methods for metabolomics research
Comparison of different nuclear magnetic resonance spectroscopy methods has helped to identify the most robust approach for studying different types of biomolecules.
12 October, 2023Lab-grown skin helps unlock secrets of mpox virus infection
Skin organoids offer a powerful platform for drug discovery in the ongoing fight against the virus formerly known as monkeypox.
26 September, 2023COVID-19 mutations and their links with excessive immune responses
Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.
07 September, 2023Cutting the odds of drug-resistant pathogens emerging in wastewater
A complex interplay of factors influences the spread of superbug genes during wastewater treatment and reuse.
24 August, 2023New gene-editing technique offers path to precision therapies
KAUST researchers have developed a gene-editing technique that provides a flexible and programmable platform for site-specific gene manipulations across all forms of DNA material.
20 August, 2023Rethinking and rigor brings promising protein for cancer therapy
Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.
20 August, 2023KAUST new strategy 2023-2030
KAUST’s strategy presents new opportunities to accelerate our positive impact on the world through alignment with the Kingdom’s Vision 2030 Research, Development, and Innovation (RDI) priorities, enhancing our global and local partnerships, and focusing on commercialization and economic impact.